AstraZeneca PLC
AZN• NASDAQ
$186.68
-0.83-0.44%
In the past 24 hours
No 24-hour summary has been generated yet.
Financial highlights
Latest saved period: December 2025 · 2025-12-31
Revenue
$15.50B
Net income
$2.33B
Free cash flow
$1.38B
Diluted EPS
—
Gross margin
79.89%
Profit margin
15.00%
Assets
$114.07B
Cash
$5.71B
Valuation
Market Cap$289.41B
Enterprise Value$315.25B
PE (TTM)14.26
PE (Fwd)18.12
Price to Sales4.93
EV / EBITDA16.16
Price to Book3.00
PEG Ratio1.55
Cash Flow
FCF Yield3.65%
FCF / Share$13.54
SBC-Adj FCF Yield—
SBC-Adj FCF / Share$13.54
SBC Impact—
Margins & Growth
Gross Margin81.90%
Operating Margin23.40%
Profit Margin17.41%
Quarterly Rev YoY+4.11%
Quarterly EPS YoY+55.07%
Balance
Cash$5.71B
Debt$28.28B
Net Debt$22.57B
Current Ratio0.94
Debt / Equity58.11
Dividend
Dividend Yield3.41%
Payout Ratio48.63%
DPS (TTM)$6.37
Last Ex-Date2026-02-20
Dividend history
Cash dividends by ex-date, not an investment recommendation.
Trailing 12 months
$3.20
Latest dividend
$2.17 · Feb 20, 2026
First record
Sep 24, 1993
Next ex-date
—
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Feb 20, 2026 | $2.17 | Mar 23, 2026 | Semiannual |
| Aug 8, 2025 | $1.03 | Sep 8, 2025 | Semiannual |
| Feb 21, 2025 | $2.10 | Mar 24, 2025 | Semiannual |
| Aug 9, 2024 | $1.00 | Sep 9, 2024 | Semiannual |
| Feb 22, 2024 | $1.97 | Mar 25, 2024 | Semiannual |
| Aug 10, 2023 | $0.93 | Sep 11, 2023 | Semiannual |
| Feb 23, 2023 | $1.97 | Mar 27, 2023 | Semiannual |
| Aug 11, 2022 | $0.93 | Sep 12, 2022 | Semiannual |
| Feb 24, 2022 | $1.97 | Mar 28, 2022 | Semiannual |
| Aug 12, 2021 | $0.90 | Sep 13, 2021 | Semiannual |
| Feb 25, 2021 | $1.90 | Mar 29, 2021 | Semiannual |
| Aug 13, 2020 | $0.90 | Sep 14, 2020 | Semiannual |
| Feb 27, 2020 | $1.90 | Mar 30, 2020 | Semiannual |
| Aug 8, 2019 | $0.90 | Sep 9, 2019 | Semiannual |
| Feb 28, 2019 | $1.90 | Mar 27, 2019 | Semiannual |
| Aug 9, 2018 | $0.90 | Sep 10, 2018 | Semiannual |
| Feb 15, 2018 | $1.90 | Mar 19, 2018 | Semiannual |
| Aug 9, 2017 | $0.90 | Sep 11, 2017 | Semiannual |
| Feb 15, 2017 | $1.90 | Mar 20, 2017 | Semiannual |
| Aug 10, 2016 | $0.90 | Sep 12, 2016 | Semiannual |
| Feb 18, 2016 | $2.08 | — | — |
| Feb 17, 2016 | $1.90 | Mar 21, 2016 | Semiannual |
| Aug 13, 2015 | $1.00 | — | — |
| Aug 12, 2015 | $0.90 | Sep 14, 2015 | Semiannual |
Price
+83.62%
Jul 19, 2021 - Apr 28, 2026 · 1,200 daily points
Revenue
↑ 144.0%Net Income
↑ 198.2%Free Cash Flow
↑ 680.8%Diluted EPS
No data
Quick Stats
Open
$186.91
Day High
$187.98
Day Low
$185.41
Prev Close
$187.51
Market Cap
—
Volume
2,834,389
AstraZeneca PLC (AZN) analysis
Wrqti brings AstraZeneca PLC data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Available price
$186.68
Market cap
$289.41B
PE ratio
14.26
Price to book
3.00
Profit margin
17.41%
FCF yield
3.65%
Stocks related to AstraZeneca PLC
Companies in the same sector you can compare with AstraZeneca PLC: